A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam

A randomized comparison of Chloroquine versus Dihydroartemisinin-Piperaquine for the treatment of Plasmodium vivax infection in Vietnam

Pokaż inne wersje (1)

A total of 128 Vietnamese patients with symptomatic Plasmodium vivax mono-infections were enrolled in a prospective, open-label, randomized trial to receive either chloroquine or dihydroartemisinin–piperaquine (DHA-PPQ). The proportions of patients with adequate clinical and parasitological response...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Thuan, P, Ca, N, Toi, P, Nhien, N, Thanh, N, Anh, N, Phu, N, Thai, C, Thai, L, Hoa, N, Dong, L, Loi, M, Son, D, Khanh, T, Dolecek, C, Nhan, H, Wolbers, M, Thwaites, G, Farrar, J, White, N, Hien, T
Format:	Journal article
Wydane:	American Society of Tropical Medicine and Hygiene 2016

Podobne zapisy

A randomized comparison of chloroquine versus dihydroartemisinin-piperaquine for the treatment of Plasmodium vivax infection in Vietnam
od: Thuan, PD, i wsp.
Wydane: (2016)

Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
od: Thanh, N, i wsp.
Wydane: (2017)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
od: Awab, G, i wsp.
Wydane: (2010)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
od: Phyo, A, i wsp.
Wydane: (2011)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenafi Assefa, i wsp.
Wydane: (2022-12-01)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
od: Ashenaf Assefa, i wsp.
Wydane: (2023-04-01)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
od: Jean Popovici, i wsp.
Wydane: (2018-08-01)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
od: Poespoprodjo, JR, i wsp.
Wydane: (2014)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
od: Woodrow Charles J, i wsp.
Wydane: (2010-04-01)

Efficacy and safety of dihydroartemisinin-piperaquine.
od: Myint, H, i wsp.
Wydane: (2007)

Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
od: Tran, T, i wsp.
Wydane: (2004)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
od: Armedy Ronny Hasugian, i wsp.
Wydane: (2016-03-01)

Artemisinin-napthoquine versus dihydroartemisinin-piperaquine in adult subjects with Plasmodium vivax infection
od: Armedy Ronny Hasugian, i wsp.
Wydane: (2016-03-01)

Treatment failure of dihydroartemisinin/piperaquine for plasmodium falciparum malaria, Vietnam
od: Phuc, B, i wsp.
Wydane: (2017)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
od: Chotsiri, P, i wsp.
Wydane: (2017)

A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
od: Pasaribu, A, i wsp.
Wydane: (2013)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
od: Zongo, I, i wsp.
Wydane: (2014)

Amodiaquine plus artesunate versus dihydroartemisinin-piperaquine for drug resistant P.falciparum and P.vivax in Papua, Indonesia
od: Armedy, R, i wsp.
Wydane: (2006)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
od: Rijken, M, i wsp.
Wydane: (2011)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
od: Tarning, J, i wsp.
Wydane: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
od: Tarning, J, i wsp.
Wydane: (2012)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
od: Hien, T, i wsp.
Wydane: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
od: Tarning, J, i wsp.
Wydane: (2008)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
od: Permala, J, i wsp.
Wydane: (2017)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
od: Hien, T, i wsp.
Wydane: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
od: Tarning, J, i wsp.
Wydane: (2007)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
od: Hasugian, A, i wsp.
Wydane: (2007)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
od: Mytton, O, i wsp.
Wydane: (2007)

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
od: Price, R, i wsp.
Wydane: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
od: Chotsiri, P, i wsp.
Wydane: (2019)

Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
od: Hanboonkunupakarn, B, i wsp.
Wydane: (2014)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
od: Bui Quang Phuc, i wsp.
Wydane: (2017-04-01)

Chloroquine versus hihydroartemisinin-piperaquine with standard high-dose Primaquine given either for 7 days or 14 days in Plasmodium vivax malaria
od: Chu, C, i wsp.
Wydane: (2018)

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis.
od: Robert J Commons, i wsp.
Wydane: (2019-10-01)

Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia
od: Puji B. S. Asih, i wsp.
Wydane: (2022-03-01)

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
od: van Der Pluijm, R, i wsp.
Wydane: (2019)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
od: Poespoprodjo, J, i wsp.
Wydane: (2015)

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: a systematic review and individual patient data meta-analysis
od: Commons, RJ, i wsp.
Wydane: (2019)

Therapeutic Efficacy and Safety of Dihydroartemisinin-Piperaquine (DP) for the Treatment of Uncomplicated Plasmodium Vivax Malaria: A Single Center Study
od: Salma Shaikh, i wsp.
Wydane: (2017-06-01)

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.
od: Cho Naing, i wsp.
Wydane: (2013-01-01)